Tim Wilsdon is a moderator on an invited issues panel entitled “What is the Road Map to the Effective Permanent Cooperation.”
Justus Dehnen’s poster “Statistical Trend Analysis of German Benefit Ratings and their Correlation with Negotiated Rebates Focusing on Orphan Oncologic” is on display on Monday, November 6 along with a poster presentation in the afternoon.
CRA will also be exhibiting at this conference.
For more information on this event, click here.
Evidence requirements for orphan drugs
CRA’s Life Sciences Practice focuses on global policy, commercialization, and market access issues dedicated to orphan drug issues, including orphan evidence...